Evaluation of ventricular arrhythmias;Die abklärung von ventrikulären rhythmusstörungen

Praxis

Volumn 85, Issue 7, 1996, Pages 179-187

  Osswald, S ^a   Rickendacher, P ^a   Buser, P T ^a   Pfisterer, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diagnostic assessment; Myocardial infarction; Sudden death; Ventricular arrhythmias

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CATHETER ABLATION; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART FUNCTION TEST; HEART VENTRICLE; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; HEART FUNCTION TESTS; HEART VENTRICLES; HUMANS;

EID: 3643094840     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Gillum R. F.: Sudden coronary death in the United States. Circulation 79, 756-765, 1989.
2. Myerburg R. J., Sudden cardiac death - epidemiology, causes, and mechanisms. Cardiology 2, 2-9, 1987.
3. Wilber D. J., Garan H., Finkelstein D. et al.: Out-of-hospital cardiac arrest. Use of eletrophysiological testing in the predicition of long-term outcome. New Engl. J. Med. 318, 19-24, 1988.
4. Osswald S, Trouton T. G., O'Nunain S.S. et al.: Work-up and assessment of risk for sudden death - patients with cardiac arrest and documented ventricular fibrillation. In: Sudden cardiac death - prevalence, mechanisms and approaches to diagnosis, Akhtar M., Mycrburg, R. J. Ruskin J. N. (eds.). Williams and Wilkins Malvern (USA), pp. 465-487, 1994.
5. Burkart F, Pfisterer M. E, Kiowski W. et al.: Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias. The Basel Antiarrhythmic Study of Infarct Survival (BASIS). J. Am. Coll. Cardiol. 16, 1711-1718, 1990.
6. Pfisterer M. E., Kowski W., Brunner H., Burckhardt D., Burkart F.: Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 87, 309-311, 1993.
7. Ceremuzynski L., Kleczar E, Krzeminska-Pakula M. et al.: Effect of amiodarone on mortality after myocardial infarction - a double-blind, placebo-controlled pilot study. J Am. Coll. Cardiol. 20, 1056-1062, 1992.
8. Yusuf S., Peto R., Lewis J. et al.. Beta blockade during and after myocardial infarction - an overview of the randomized trials. Prog. Cardiovasc. Dis. 17, 335-371, 1985.
9. CAST Investigators, preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl. J. Med. 321, 406-412, 1989.
10. Echt D. S., Liebson P. R., Mitchell B. et al.: Mortality and morbidity in patients receiving encainide, flecainide or placebo. New Engl. J. Med. 324, 781-788, 1991.
11. Julian D. G., Jackson F. S., Prescott R. J. et al.: Controlled trial for sotalol for one year after myocardial infarction Lancet I, 1142-1147, 1982.
12. Waldo A. L., Camm A. J., de Ruyter H. et al.: Preliminary mortality results from the Survival without oral d-sotalol (SWORD) trial. J. Am. Coll. Cardiol. 25, 15A, 1995.
13. Tea K. K., Yusuf S., Furberg C D.: Effects of antiarrhythmic drug therapy in acute myocardial infarction. J. Am. med. Ass. 270, 1589-1595, 1993.
14. Poole J. E., Mathisen T. L., Kudenchuck P. J. et al.: Long-term outcome in patients who survived out-of-hospital ventricular fibrillation and who undergo electrophysiologic studies - evaluation by electrophysiologic subgroups. J. Am. Coll. Cardiol. 16, 657-665, 1990.
15. Powell A. C., Fuchs T., Finkelstein D. M. et al.: Influence of the automatic implantable cardioverter-defibrillator on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 88, 1083-1092, 1993.
16. Akhtar M., Garan H., Lehmann M. H et al.: Sudden cardiac death - management of high-risk patients. Ann. intern. Med. 114, 499-512, 1991.
17. Garan H., Ruskin J. N.: Localized reentry. Mechanism of induced sustained ventricular tachycardia in canine model of recent myocardial infarction. J. clin. Invest. 74, 377-392, 1984.
18. Garan H., Fallon J. T., Rosenthal S, et al.: Endocardial, intramural, and epicardial activation patterns during sustained monomorphic ventricular tachycardia in late canine myocardial infarction. Circ. Res. 60, 879-896, 1987.
19. Myerburg R. J., Kessler K. M., Bassett A. L., et al.: A biological approach to sudden cardiac death - structure, function and cause. Am. J. Cardiol. 63, 1512-1516, 1989.
20. Multicenter Postinfarction Research Group: Risk stratification after myocardial infarction. New Engl. J. Med. 309, 331-336, 1983.
21. Maggioni A. P., Zuanetti G., Franzosi M. G. et al.: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87, 312-322, 1993.
22. Pfisterer M., Salamin P. A., Schwendener R et al.: Clinical risk assessment after myocardial infarction. Is additional noninvasive testing necessary? Chest 102, 1499-1506, 1992.
23. Holmes D. R. J., Davis K. B , Mock M. R. et al.: The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease. A report from the Coronary Artery Surgery Study. Circulation 73, 1254-1263, 1986.
24. Holmes D R. J., Davis K., Gersh B J. et al.: Risk factor profiles of patients with sudden cardiac death and death from other cardiac causes A report from the Coronary Artery Surgery Study (CASS). J. Am. Coll. Cardiol. 13, 524-530, 1989.
25. Ruberman W., Weinblatt E., Goldberg J. D.: Ventricular premature beats and mortality after acute myocardial infarction. New Engl. J. Med. 297, 750-757, 1977.
26. Moss A. J., Davis H. T., De Camilla J. et al.: Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation, 998-1003, 1979.
27. Bigger J. T., Fleiss J. L., Kleiger R. et al.: The relationship between ventricular arrhythmias, left-ventricular dysfunction, and mortality in the two years after myocardial infarction. Circulation 69, 250-258, 1984.
28. Mukharji J., Rude R. E , Pools W. K. et al.: The MILLIS Study Group. Risk factors for sudden death after acute myocardial infarction - two-year follow-up. Am. J. Cardiol. 54, 31-36, 1984.
29. Kostis J. B., Byington R., Friedman L. M. et al.: Prognostic signifcance of ventricular ectopic activity in survivors of acute myocardial infarction. J. Am. Coll. Cardiol. 10, 231-242, 1987.
30. Simson M. B.: Noninvasive identification of patients at high risk for sudden cardiac death. Signal-averaged electrocardiography. Circulation 51, 1145-1151, 1992.
31. Breithardt G., Schwarzmater M., Borggrefe M. et al.: Prognostic significance of late potentials after myocardial infarction. Eur. Heart J. 4, 487-495, 1983.
32. Denniss A. R., Richards D. A., Cody D. V. et al.: Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 74, 731-745, 1986.
33. Kuchar D. L., Thorburn C. W., Samuel N. L.: Late potentials detected after myocardial infarction. Natural history and prognostic significance. Circulation 74, 1280-1289, 1986.
34. Gomes J. A., Winters S. L., Martinson M. et al.: The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats. A prospective study. J. Am. Coll. Cardiol. 13, 377-384, 1989.
35. Cripps T. R., Bennett E. D., Camm A. J. et al. High-gain signal averaged electrocardiogram, combined with 24-hours monitoring in patients early after myocardial infarction for bedside prediction of arrhythmic events. Br. Heart J. 60, 181-188, 1989.
36. El-Sherif N., Ursell S. N., Bekheit S. et al.: Prognostic significance of the signal-averaged ECG depends on the time of recording in the postinfarction period. Am. Heart J. 118, 256-264, 1989.
37. Gomes J. A., Winters S. L., Ip J. et al.: Identification of patients with high risk of arrhythmic mortality. Role of ambulatory monitoring signal-averaged ECG, and heart rate variability. Cardiol. Clin. 11, 55-63, 1993.
38. Farell T. G., Bashir Y., Cripps T. et al.: Risk stratification for arrhythmic events in postinfarction patients, based on heart rate variability, ambulatory electrocardiographic variables and signal-averaged electorcardiogram. J. Am. Coll. Cardiol. 18, 687-697, 1991.
39. Kuchar D. L , Thorburn C. W., Freund J. et al.: Noninvasive predictors of cardiac events after myocardial infarction. Complementary value of exercise testing and signal-averaged electrocardiography. Cardiology 76, 18-31, 1989.
40. Doval H. C., Nul D. R., Grancelli H. O. et al.: Randomized trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 344, 493-498, 1994.
41. Garan H., Ruskin J. N., DiMarco J. P. et al.: Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias. Am. J. Cardiol. 51, 519-524, 1983.
42. Kelly P., Ruskin J. N., Vlahakes G. J. et al.: Surgical coronary revascularization in survivors of prehospital cardiac arrest - its effect on inducible ventricular arrhythmias and long-term survival. J. Am. Coll. Cardiol. 15, 267-273, 1990.
43. Ruskin J. N.: Role of invasive electrophysiological testing in the evaluation and treatment of patients at high risk for sudden cardiac death. Circulation 85 (Suppl. I), I 152-I 159, 1992.
44. Ruskin J. N., Dimarco J. P., Garan H.: Out-of-hospital cardiac arrest - electrophysiologic observations and selection of long-term anti-arrhythmic therapy. New Engl. J. Med. 303, 607-613, 1980.
45. Mason J. W.: ESVEM-Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. New Engl. J. Med. 329, 452-458, 1993.
46. Mason J. W: Implications of the ESVEM trial for use of antiarrhythmic drugs that prolong cardiac repolarization. Am. J. Cardiol. 72, 59F-61F, 1993.
47. Osswald S., Candinas R., Fuhrer J.: Erste klinische Erfahrungen mit einem neuen implantierbaren Cardioverter-Defibrillator: Eine prospektive Evaluation an drei schweizerischen Universitätszentren. Schw. med. Wschr., 1995.
48. Fromer M., Brachmann J., Block M. et al.: Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Circulation 86, 363-374, 1992.